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Genetic Manipulation of Leishmania Parasites Facilitates the Exploration
of the Polyamine Biosynthetic Pathway as a Potential Therapeutic Target
Abstract
Parasites of the genus Leishmania cause a variety of devastating and often fatal diseases, ranging from
cutaneous ulcerative lesions to fatal visceralizing infections that affect an estimated 12 million people
worldwide. Unfortunately, vaccines are not available and the cturent arsenal of drugs used to treat
leishmaniasis is far from ideal. Thus the need for new therapeutic targets and a better understanding of host-
parasite interactions is urgent. One biochemical pathway that has been successfully exploited for the treatment
of a related parasitic disease, African trypanosomiasis, is the polyamine biosynthetic pathway. In order to
elucidate the polyamine biosynthetic pathway and to explore its potential as a therapeutic target in
Leishmania, we have generated and characterized gene deletion mutants and polyamine enzyme overproducer
strains. These studies revealed that the polyamine pathway in Leishmania is significantly different from that of
the mammalian host and polyamines were found to be essential for parasite proliferation. Infectivity studies in
macrophages and mice with gene deletion mutants revealed that at least two polyamine biosynthetic enzymes,
ornithine decarboxylase and spermidine synthase, are necessary for Leishmania donovani to establish a
successful infection. However, arginase gene deletion mutants of Leishmania mexicana are still capable of
eliciting an infection, albeit at lower levels than wild type parasites. Ongoing studies address whether the
disparities in infectivity are due to the loss of specific enzymes within the pathway or to differences between
the two Leishmania species. Furthermore, the gene deletion mutants are useful tools to investigate the relative
contribution of host and parasite polyamine biosynthetic enzymes in parasite infectivity. This chapter will
summarize how genetic manipulations in Leishmania have advanced our understanding of the polyamine
pathway and its role in host-parasite interactions.
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Chapter II 
Genetic Manipulation of Leishmania 
Parasites Facilitates the Exploration 
of the Polyamine Biosynthetic Pathway 
As a Potential Therapeutic Target 
Sigrid C Roberts* 
Pacific University School ofPhrumacy, Hillsboro, Oregon, US 
Abstract 
Parasites of the genus Leishmania cause a variety of devastating and often fatal 
diseases, ranging from cutaneous ulcerative lesions to fatal visceralizing infections that 
affect an estimated 12 million people worldwide. Unforttmately, vaccines are not 
available and the cturent arsenal of drugs used to treat leishmaniasis is far from ideal. 
Thus the need for new therapeutic targets and a better tmderstanding of host-parasite 
interactions is urgent. One biochemical pathway that has been successfully exploited for 
the treatment of a related parasitic disease, African trypanosomiasis, is the polyamine 
biosynthetic pathway. In order to elucidate the polyamine biosynthetic pathway and to 
explore its potential as a therapeutic target in Leishmania, we have generated and 
characterized gene deletion mutants and polyamine enzyme overproducer strains. These 
studies revealed that the polyamine pathway in Leishmania is significantly different from 
that of the mammalian host and polyamines were fotmd to be essential for parasite 
proliferation. Infectivity studies in macrophages and mice with gene deletion mutants 
revealed that at least two polyamine biosynthetic enzymes, omithine decarboxylase and 
spemlidine synthase, are necessary for Leishmania donovani to establish a successful 
infection. However, arginase gene deletion mutants of Leishmania mexicana are still 
capable of eliciting an infection, albeit at lower levels than wild type parasites. Ongoing 
studies address whether the disparities in infectivity are due to the loss of specific 
enzymes within the pathway or to differences between the two Leishmania species. 
Furthe1more, the gene deletion mutants are useful tools to investigate the relative 
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contribution of host and parasite polyamine biosynthetic enzymes in parasite infectivity. 
This chapter will smmnarize how genetic manipulations in Leishm.ania have advanced 
om tmderstanding of the polyamine pathway and its role in host-parasite interactions. 
Leishmania Parasites and Their 
Relevance for Human Health 
Parasites of the genus Leishmania cause a variety of devastating and often fatal diseases 
in humans and domestic animals worldwide. Leishmania belong to the order of 
trypanosomatids, which include Trypanosoma brucei, the causative agent of African sleeping 
sickness, and Trypanosoma cruzi, which produces Chagas disease. The spectmm of 
leishmaniasis ranges from cutaneous ulcerative lesions to fatal visceralizing infections and 
affects an estimated 12 million people worldwide [1 , 2]. Visceral leishmaniasis targets 
primarily the liver and spleen and is caused by L. donovani, L. infantum (Africa and Asia), 
and L. chagasi (Central and South America). This type of leishmaniasis is invariably fatal if 
not treated. Cutaneous leishmaniasis, which produces skin ulceration at the bite site, is caused 
by about 20 different Leishmania species, including L. mexicana, L. major, and L. 
amazonen.sis. A third f01m of the disease, mucocutaneous leishmaniasis, which targets and 
destroys the mucous membranes of nose and mouth, is caused by L. braziliensis in South 
Ame1ica. The specific host tissue tropism of the different Leishmania species is poorly 
understood and exceptions occur. For example, L. chagasi may lead to cutaneous 
leishmaniasis in Central America, while do1mant L. donovani parasites can trigger cutaneous 
disease years after the visceral f01m has been successfully treated as obse1ved in post kala-
azar de1mal leishmaniasis (PKDL) in India and Africa [3, 4]. 
Leishmania has a digenetic life cycle in which the extracellular promastigote f01m resides 
in the sand fly vector, whereas the intr·acellular amastigote f01m inhabits the phagolysosome 
of macrophages in the infected host. The flagellated promastigote resides in the gut of the 
sand fly but will eventually migrate to the proboscis of the insect. Here, metacyclic or 
infective promastigotes will be regurgitated into the bite site when the sand fly takes a blood 
meal. Leishmania promastigotes are then phagocytosed by host macrophages. Usually, 
phagosomes fuse with lysosomes to f01m phagolysosomes, which are a highly effective in 
killing foreign pathogens. However, Leishmania parasites inhibit phagolysosomal maturation 
and withstand the hostile environment. Promastigotes conve1t into the smaller, non-flagellated 
amastigotes, which proliferate inside this host cell compartment. When a sandfly takes a 
blood meal from an infected host, it ingests parasitized macrophages and the released 
amastigotes tr·ansfOim back into promastigotes, completing the life cycle. 
Due to the absence of effective vaccines, therapeutic treatment has offered the only 
avenue of defense against leishmaniasis and other parasitic diseases [5-7] . Dmg treatment of 
the different fo1ms of leishmaniasis, however, is far from ideal with toxic side effects and 
dmg resistance limiting the effectiveness of a small number of dmgs. The toxic antimonials 
are still considered the first line of treatment and the only new dmg, miltefosine, which is also 
the only anti-leishmania! medicine that can be administered orally, is teratogenic [8]. Thus, 
the need for new therapeutic targets and a better tmderstanding of host-parasite interactions is 
urgent. 
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The Polyamine Pathway 
One pathway that has ah·eady been targeted for parasitic diseases is that of polyamine 
biosynthesis. Difluoromethylornithine (DFMO or eflomithine), which targets the first and 
rate-limiting step of tlris pathway, is a cllirically approved treatment for Afi.ican sleeping 
sickness caused by T. brucei [9-12], a parasite closely related to Leishmania. Polyamines are 
essential and ubiquitous cations that are especially important for rapidly proliferating cells 
such as parasites and cancer cells. The three biologically relevant polyanrines, putrescine, 
spemridine, and spemrine have an aliphatic carbon backbone and contain multiple amino 
groups that are positively charged under physiological conditions (Figure 1). These 
compotmds play c1itical roles in key cellular processes such as growth, differentiation, and 
macromolecular biosynthesis. However, despite numerous studies on the ftmctions of 
polyamines, their roles for cell stmcture and ftmction are still not fully tmderstood. 
The polyamine pathway has been characte1ized in detail in the mammalian host (Figure 
2). The first and rate-linriting enzyme is omithine decarboxylase (ODC), which catalyzes the 
conversion of the anrino acid omithine to putrescine. Subsequently, putrescine is metabolized 
to spemridine by the action of spernridine synthase (SPD). This enzyme catalyzes the addition 
of an aminopropyl group, which is donated fi:om decarboxylated S-adenosyhnethionine. The 
enzyme S-adenosyhnetlrionine decarboxylase (ADOMETDC) is responsible for the 
decarboxylation of S-adenosylmethionine, which comnrits the compotmd for polyamine 
biosynthesis. A second aminopropylgroup is added to spemridine to produce spemrine in a 
reaction catalyzed by spemrine synthase (SPM). In mammals, spemrine can be back-
conveited to spemridine and putrescine by the conceited actions of spemridine/spemrine 
N(l)-acetyltransferase (SSAT) and polyamine oxidase (POA). Spennidine is an essential 
polyamine that also plays a vital role in a unique modification reaction that is necessruy to 
activate eukruyotic translation initiation factor (eiFSA), a protein involved in translation and 
RNA metabolism [13, 14]. The enzyme deoxyhypusine synthase (DHS) catalyzes the addition 
of an aminopropyl group derived from spernridine to a lysine residue of eiFSA to f01m 
deoxyhypsuine and the enzyme deoxyhypusine hydroxylase (DOHH) completes the reaction 
by f01ming hypusine. 
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Figme 1. Structures of the common polyamines. 
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The enzyme abbreviations utilized are ARG: arginase; ODC: omithine decarboxylase; SPD: spe1midine 
synthase; SPM: spennine synthase; ADOMETDC: S-adenosyhnethionine decarboxylase; ADC: 
arginine decarboxylase; AGM: agmatinase; DHS: deoxyhypusine synthase; DOHH: 
deoxyhypusine hydroxylase. DFMO is difluoromethylomithine, a suicide inhibitor of ODC. The 
question mark denotes the controversial hypothesis that mammalian cells contain an ADC activity. 
Figme 2. The polyamine biosynthetic pathway in the mammalian host. 
Evidence from yeast and mammalian cells suggest that the hypusination reaction is 
indispensable for activation of eiF5A and cell viability [15, 16]. 
Spe1midine is also used in the synthesis of tlypanothione, a reaction that occms only in 
tlypanosomatid parasites. T1ypanothione is composed of two molecules of glutathione linked 
by spe1midine and plays a cmcial role in fighting oxidative stress in these pathogens [17-21]. 
Although tlypanothione metabolism is an essential and tmique pathway for tlypanosomatids, 
this therapeutically relevant pathway has been the subject of several recent review articles 
[22-25] and will therefore not be discussed ftuther in this chapter. 
An altemative pathway for pun·escine production exists in plants and some 
microorganisms where ru·ginine decarboxylase (ADC) conve1ts the amino acid arginine to 
agmatine, which is ftuther metabolized to putrescine by agmatinase (AGM) or agmatine 
deiminase and N-cru·bamoylputrescine hydrolase. While the presence of AGM in manunalian 
cells has been desc1ibed and is generally recognized, the existence of an ADC is disputed [26-
28]. 
Because polyamines ru·e a validated tru·get in the related African tlypanosomes, we used 
genetic methods to elucidate this pathway in Leishmania with the goal to evaluate its potential 
as a therapeutic tru·get. 
Genetic techniques Available for the Manipulation 
of Leishmania parasites 
Genetic manipulations can be perfo1med in Leishmania and facilitate the characterization 
of metabolic processes and the identification of proteins that ru·e impo1tant for pru·asite 
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proliferation and infectivity. The most significant tool is the ability to generate gene deletion 
mutants via targeted gene replacement. Leishmania are diploid organisms that readily 
tmdergo homologous recombination and knockout strategies are hence straightf01ward. Gene 
deletion sn1dies are an example of reverse genetic analysis where the outcome or phenotype 
of a targeted mutation is examined. The more classical method, fo1ward genetic analysis, 
attempts to discover the genetic basis of an obse1ved phenotype. 
In order to generate gene deletion mutants, constructs containing a dmg resistance 
cassette flanked by upstr·eam and downstream sequences of the target gene need to be created 
(Figure 3). Linea1ized DNA constructs are then purified and intr·oduced into the parasite by 
electr·oporation. Transfected parasites are subsequently plated on semi-solid agar plates in the 
presence of the selective dmg and colonies are picked to achieve the genetic homogeneity of 
a clonal cell line. Because Leishmania are diploid organisms, a second round of targeted gene 
replacement is necessary to create knockout par·asites. Loss of heterozygosity can also be 
induced, however, a negative selection scheme is necessa1y to stimulate the loss of the second 
gene copy. Southem blotting and/or polymerase chain reactions (PCR) are utilized to 
char·acterize the resulting genotype and to ve1ify that the anticipated homologous recom-
bination event occmTed in both heterozygous and homozygous par·asites. 
The deletion of an essential gene is only possible if the mutants can be rescued by 
nutr·ient supplementation or other salvage str·ategies. For example, the removal of polyamine 
biosynthetic pathway genes from Leishmania is possible because the auxotrophic mutants 
smvive in the presence of exogenous polyamines. Knockouts of essential genes callllot be 
perfo1med if rescue str·ategies ar·e unavailable. 
A Electroporation C Selection 
s Q 
~ 
Homologous recombination 
and gene replacement 
~
D Expansion 
Confirmation 
of genotype 
by Southern 
blot or PCR 
0 
....,_, .... 
AReplacement constructs are introduced into parasites via electroporation. BThe target gene is replaced 
with the dmg resistance cassette when homologous recombination occms. <1>arasites are plated on 
semi-solid agar plates containing the selective dmg and colonies are picked. °Colonies are 
expanded in liquid media. TI1e genotype is confmned by Southem blotting or PCR analysis. The 
process is subsequently repeated to replace the second gene with a different dmg resistance 
marker. 
Figme 3. Targeted gene replacement. 
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However, the ability to generate chromosomal gene deletions in the presence, but not 
absence, of episomes that express the targeted gene is one way to demonstrate that a gene is 
indispensable [29, 30]. 
An important control experiment is to generate complemented or add-back strains, where 
the deleted gene is re-introduced into the knockout strain either on an episome or as a 
chromosomal integration [31-38]. Compmison of the knockout cell line and the 
complemented strain ensure that the obse1ved phenotypic changes are indeed caused by the 
gene deletion event and not by other sporadic mutations or adaptations that might have 
OCCUlTed. 
The opposite of gene deletion, the introduction of genes into Leishmania pm·asites, is also 
possible. Constlucts containing endogenous genes can be inn·oduced to generate ove1producer 
sn·ains and the phenotypic characte1ization of the resultant mutant can provide valuable 
info1mation about the target gene. Fmthe1more, genes from different species can be 
n·ansfected to create n·ansgenic pm·asites. Endogenous or exogenous genes can be inn·oduced 
as pa1t of an episome or stably integrated into the chromosome. Advantages of these 
expression systelllS range from the introduction of repo1ter genes to facilitate imaging of 
fusion proteins or whole organisms in in vivo infections [39-41], expression and pmification 
of recombinant proteins [42-44], and ftmctional studies that help to identify genes involved in 
dmg sensitivity, protism, vimlence or the host immune response [ 45-48]. 
It is impo1tant to note that the cultivation of Leishmania pm·asites is straightfmwm·d. 
Exn·acellular parasites can be maintained as the promastigote (insect) fmm indefinitely and in 
large quantities in liquid culture medium. Amastigotes can also be cultured as an exn·acellular 
or axenic fmm by utilizing acidic media and higher temperatures, which mimic the host 
phagolysosomal environment. Although axenic amastigotes m·e only a model system and not 
t111e inn·acellular amastigotes, the advantage is that pm·asite metabolism can be nun·itionally 
and biochemically characterized without the contamination of host components. Fmthe1more, 
infectivity studies in vitro in macrophages as well as in vivo in mice and halllSters are now 
routinely perfo1med. 
The Polyamine Pathway in Promastigotes 
We initiated our analysis of the polyamine pathway in Leishmania by generating gene 
deletion mutants in L. donovani promastigotes. Three knockout lines, LdAodc, LdAspd, and 
LdAadometdc, were created [32, 33, 35]. In addition, complemented conn·ol cell lines were 
generated that contained copies of the deleted genes on episomes; LdAodc [ODC}, LdAspd 
[SPD}, LdAadometdc [ADOMETDC]. The knockout mutants were not able to produce 
pun·escine (LdAodc) or spe1midine (LdAodc, LdAspd, LdAadometdc) confuming that no 
altemative pathways for polyamine production m·e present in Leishmania parasites. As 
expected, the genetically manipulated promastigotes require polyamine supplementation for 
smvival. The LdAodc parasites are able to grow in spe1midine; however, much higher concen-
n·ations of spe1midine compared to pun·escine are required [32]. 
Thus, spe1midine is sufficient and essential for promastigote proliferation; but pun·escine 
is necessa1y for optimal proliferation. This obse1vation suggests that pun·escine is not merely 
a precursor for spe1midine synthesis but plays an additional and impo1tant role in Leishmania. 
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Polyrunine pool analysis of pru·asites revealed that spennine is not being produced by the 
parasite (Figure 4) and a spennine synthase gene is not present in the annotated genome 
databases of Leishmania species. This is an unexpected discove1y, as spennine is postulated 
to be a crucial metabolite in mammalian cells [49]. 
arginine AAP/ 3 ,...... ar~nine 
arginine \ E>l glycosome 
ornithine ornithine ~ 
• { orn~hine 
putrescine ~· ~~ Leishmania 
spermidine \ promast/gote 
. ··-··r ·J .... :., putrescine 
pWescone '----. __ ·s:···. @ j 
spermidine :-::7.:::::_·:·> spermidine 
'• 
Transp01ters for arginine (AAP3) and for putrescine/spemlidine (POTl) have been identified on the 
molecular level. Ornithine transp01t has been characterized. Individual transpotters for putrescine 
and spennidine have been proposed. Parasite ARG is located in the glycosome, necessitating 
import of arginine into the glycosome and expoti of omithine from the glycosome to the cytosol. 
ODC, SPD, and ADOMETDC (not shown) are located in the cytosol. 
Figure 4. Polyrunine biosynthesis and transpoti in Leishmania promastigotes. 
Analysis of the knockout parasites also revealed that the back·conversion pathway 
present in mammalian cells is lacking in Leishmania (Figure 4). Spemtidine cannot be 
conve1ted to putrescine. Sintilarly, spemrine, although taken up by pru·asites, is not ftuther 
metabolized or utilized [32]. Fmthe1more, the half·live of the leishmania! ODC and 
ADOMETDC proteins ru·e much longer than that of their human counterpruts [35, 50]. This is 
a relevant obse1vation since the selectivity of the suicide inhibitor DFMO for T brucei is 
based on the fact that ODC is a stable enzyme in the pru·asite but is rapidly tmned over in the 
human host; DFMO binds to human and pru·asite ODC with sinrilar affmities [51] but the 
human protein is re·synthesized continuously. 
More recently, investigations into the hypusine pathway have been initiated in protozoan 
pathogens [29, 52-56]. Leishmania pru·asites contain two putative DHS genes (DHSL20, 
DHS34) and one putative DOHH gene [29, 52]. Biochenrical characterization of the proteins 
encoded by the two putative DHS genes revealed that one protein (DHSL20) was not 
ftmctional as a DHS but the other protein, DHS34, expressed the expected catalytic activity 
[29]. Unf01tunately, gene deletion mutants of DHS or DOHH cannot be generated if the 
enzymes ru·e essential, because rescue by supplementing modified eiF5A is not possible. As 
expected, a DHS null mutant could not be produced. However, chromosomal knockouts were 
generated in cell lines that cruTied an episome containing the DHS coding sequence [29]. This 
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circumstantial evidence implies that DHS is an essential enzyme in Leishmania. Interestingly, 
the sequence of the ftmctional and indispensable DHS protein is strikingly different from the 
human DHS, with unique inse1t ions and an overall low identity of 32.8%, evoking the 
possibility that selective inhibitors may be identified. 
Taken together, the characterization of the gene deletion mutants in the promastigote 
stage of Leishmania validates the polyamine pathway as a prospective therapeutic target. The 
biosynthetic enzymes are necessary for the synthesis of the essential polyamines and the 
pathway is substantially different fi"om the human polyamine pathway. 
These dispa1ities include the absence of SPM and the lack of a back-conversion pathway 
in Leishmania, substantial sequence differences in the sequence of at least some of the 
polyamine enzymes compar·ed to the human cmmterpa1ts, and the varied half-lives of the 
human and par·asite ODC and ADOMETDC proteins. 
Effect of Polyamine Analogues 
on Promastigote Proliferation 
Several groups have examined the effects of polyamine analogues on Leishmania 
proliferation and infectivity. DFMO is toxic to Leishmania promastigotes, axenic amastigotes 
and intracellular· amastigotes in macrophages [36, 57-60]. Fmthe1more, the dmg inhibits 
par·asite proliferation in mice and hamsters [61-64]. 
Several other ODC inhibitors have been evaluated: 3-aminooxy-1-aminopropane (APA), 
1,4 -diamino-2-butanone (DAB), and gamma-guanidinooxypropylamine (GAPA) inhibit 
proliferation ofpromastigotes and amastigotes, and ftnthe1more APA and DAB have shown 
to reduce macrophage infectivity substantially [ 65-67]. 
Table 1. Amino acid sequence comparison of Leisltmallia and mammalian polyamine 
biosynthetic enzymes 
Leishmania protein Sequence identity to human 
cotmterpatt Reference 
L. mexicana ARG 38.5% Roberts et al. 2004 
L. donovani ODC 40%(to murine counterpart) Hanson et al. 1992 
L. donovani SPD 56% Roberts et al. 2001 
L. donovani ADOMETDC 30% Roberts et al. 2002 
L. donovani DHS34 32.8% Chawla et al. 201 0 
L. donovani DOHH 40.6% Chawla et al. 2012 
DAB and GAPA inhibit putrescine uptake [65, 67], and DAB causes mitochondrial 
damage [ 67], indicating that putrescine may be pa1ticular·ly impo1tant for mitochondlial 
ftmction or stmctme. Moreover, DFMO, APA and DAB ar·e not toxic to macrophages at 
concentrations that profmmdly affect the ability of the par·asite to grow [36, 66]. Bis (benzyl) 
polyamine analogues, known inhibitors of both ODC and ADOMETDC enzyme activity, 
lower intracellular· polyamine levels in vitro [68], and administration of N,N'-bis(3-
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[(phenylmethyl) amino] propyl)-1,7-diaminoheptane (MDL27695) suppresses L. donovani 
liver burden in mice by 50% [63] or 99% [69]. Recently, the stmcture of the leishmania! ODC 
bmmd to AP A has been modeled according to the solved crystal stmcnu·e of the hmnan ODC 
- APA complex [70]. The stmcnu·e, kinetic propetties, and half-life of the leishmania! ODC 
are substantially different from the hmnan cotmterprut [50, 70] and the stmcnu·al information 
may prove useful for the design or computer-based screening of novel ODC inhibitors. 
Overproducer Strains As Tools to Investigate 
the Mode of Action of Polyamine Analogues 
To test whether polyamine analogues indeed target enzymes of the polyamine pathway, a 
cell based screening assay has been developed that takes advantage of polyamine enzyme 
overproducing strains. The genetically manipulated pathogens are used as tools to investigate 
the mode of action of cytotoxic analogs in Leishmania based on the prediction that enzyme 
overproducer strains will be more resistant to a dmg that specifically targets the overproduced 
protein. Wild type pru·asites were transfected with episomal constmcts containing the ODC, 
SPD, or ADOMETDC gene. The episomal constmcts also contained dmg resistance markers 
that allowed selection of transfected parasites. Fmthetmore, increased dmg concentrations 
facilitated the overexpression of the polyrunine biosynthetic proteins, presumably due to the 
high copy number of the episomes. Wild type and oveiproducer strains were then incubated 
in serial inhibitor dilutions and the EC [50] values were compared. These expetiments 
confumed that DFMO, 5-([(Z)-4-amino-2-butenyl] methylamino)-5-deoxyadenosine 
(AbeAdo or MDL73811), and n-butylamine tru·get ODC, ADOMETDC, and SPD, 
respectively, as had previously been proposed [71-73]. Conversely, pentrunidine, berenil, and 
methylglyoxal bis (guanylhydrazone) (mitoguazone or MGBG) did not kill pru·asites via 
polyrunine enzyme inhibition. These compounds have previously been speculated to be toxic 
solely due to inhibition of the polyamine biosynthetic enzymes but other cellulru· tru·gets have 
also been proposed [74-80]. The overproducer strains were utilized for a pilot screen of 25 
compmmds and we demonstrated that this system offers a rapid cell-based screen for 
assessing whether synthetic polyrunine analogs exett their toxicity predominantly by targeting 
the polyamine biosynthetic enzymes in Leishmania. Ultimately, the dmg resistance induced 
by amplification of tru·get genes and resulting overproduction of the encoded protein offers a 
general strategy for evaluating the mode of action of therapeutic agents. 
Relevance of the Polyamine Biosynthetic 
Pathway for Leishmania Infectivity 
Although stt1dies in promastigotes were promising, the ultimate validation of the 
polyrunine pathway as a medical target requires the evaluation of the infective runastigote 
stage of the pru·asite. A long debated but tmsolved question remained whether amastigotes 
were capable of salvaging polyamines from the phagolysosomal comprutment in 
macrophages. On the one hand, sh01t tetm infectivity studies in mice and hrunsters revealed 
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substantial growth inhibition of intracellular parasites with administration ofDFMO, although 
parasites were not eradicated [61-64]. On the other hand, the phagolysosome has been 
posnllated to be lich in nuuients, including polyamines [81-84], and polyamine uptake has 
been demonstrated in both the promastigote and amastigotes fmm [85-88]. Thus, the 
prevailing belief has been that Leishmania parasites reside in a polyamine rich environment 
and that the polyamine biosynthetic pathway would therefore not be a promising therapeutic 
target. Gene deletion mutants present an ideal tool to solve this conu·oversy since these 
organisms are not able to synthesize endogenous polyamines and thus depend on salvage of 
polyarnines for proliferation. 
When peritoneal macrophages were infected with wild type and LdAodc parasites, a 
substantial reduction in pathogen per macrophage were obse1ved 72 hours after infection 
[36]. These results were minored in murine infectivity studies that revealed a profound 
reduction in parasite number in both liver and spleen after 4 weeks of infection. The average 
number of parasites per gram liver was ~ 108 in mice infected with wild type L. donovani but 
only ~102 parasites in mice infected with LdAodc cell lines [36]. Adminisu·ation ofpuu·escine 
to the dlinking water of the infected mice partially restored the loss of infectivity of LdAodc 
par·asites, demonsu·ating that the reduced inu·acellular· smvival was indeed due to the deletion 
of ODC and lack of endogenous puu·escine synthesis [ 64]. Similar results were obtained when 
LdAspd par·asites were used in mmine infectivity studies [38]. However, a slightly higher 
number of LdAspd par·asites were recovered from the livers of infected mice ( ~ 103 organisms 
per gram liver) compared to LdAodc (~102 organisms per gram liver). The cause for this 
dispa1i ty in infectivity phenotype between the LdAodc and LdAspd par·asites is unclear· but 
could be due to differences in either the am01mt of available puu·escine versus spe1midine in 
the phagolysosomal compa1tment or differential uptake abilities of inu·acellular· amastigotes. 
These infectivity studies demonsu·ated that ODC and SPD ar·e essential for a robust infection 
and that insufficient amounts of polyamines ar·e present in the phagolysosomal compa1tment. 
Because L. donovani par·asites cannot salvage sufficient amounts of puu·escine or spe1midine, 
the polyamine biosynthetic enzymes ODC, SPD, and ADOMETDC are potential targets for 
therapeutic u·eatment ofvisceral leishmaniasis. 
The Role of Parasite Arginase 
for Promastigote Proliferation 
In Leishmania, arginase (ARG) conve1ts the essential amino acid ar·ginine to omithine, 
which is then directly funneled into polyamine biosynthesis [89]. ARG gene deletion mutants 
have been generated in L. mexicana, L. major, and L. amazonensis [89-91]; all three are 
agents of cutaneous leishmaniasis. Stlldies in the promastigote stage of the par·asite 
dete1mined that the sole essential role of ARG is the synthesis of omithine for polyamine 
biosynthesis and that the gene deletion mutants required omithine or puu·escine supple-
mentation for smvival [89-91]. These sn1dies in the promastigote stage of the parasite 
establish the par·asite ARG as an essential enzyme for polyamine biosynthesis. 
Intriguingly, the leishmania! ARG sequence contains a SKL motif, which directs the 
enzyme to the glycosomal compartment, while the remaining polyamine biosynthetic 
enzymes ar·e localized to the cytosol [89]. The glycosome, an essential cellular· organelle 
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unique to Leishmania and similar parasites, is evolutionaty related to the peroxisomes of 
mammalian cells. hl Leishmania, glycosome biogenesis is essential and the organelle houses 
several cmcial metabolic and biosynthetic pathways; however, it is unknown why these 
pathways are restricted to the glycosome [92, 93]. To investigate the importance of the 
glycosomal localization for ARG ftmction, a SKL deletion mutant was expressed in the L. 
mexicana flarg backgrotmd [89]. Phenotypic characterization confnmed that the mutant 
protein was expressed at similar levels as the wild type protein and that it was tnislocalized to 
the cytosol. Proliferation studies revealed that the glycosomal localization of ARG was not 
necessruy for its ftmction in L. mexicana promastigotes [89]. Similar expetiments in L. 
amazonensis , however, found that a mislocalized ru·g!!..skl protein was expressed at only vety 
low levels in the cytosol, indicating that proper localization is significant in L. amazonensis 
promastigotes [90]. However, the promastigotes were able to smvive without omithine or 
putrescine supplementation, presumably due to residual ru·ginase activity of the ru·g!!..skl 
protein [90]. 
Another intriguing obsetvation is that although omithine is the direct product of the ARG 
reaction, much higher concentrations of exogenous omithine (>1mM) than putrescine (5- 10 
JlM) ru·e necessruy to supp01t optimal proliferation of L. mexicana flarg promastigotes [89]. 
Similar discrepancies between omithine and putrescine requirements were obsetved in L. 
major flarg promastigotes [91]. Uptake assays established that transp01t capabilities are 
similru· for omithine and putrescine in L. mexicana and thus do not accotmt for the disparity in 
nutrient requirements [89]. It is feasible, that ODC is the rate limiting enzyme for polyamine 
biosynthesis and the finding that L. me.:-cicana parasites contain much higher levels of 
intracellulru· omithine (~130 nmol/107 parasites) than putrescine (~2.5 nmol/107 parasites) 
supp01t s this conjectme [89]. The obsetvation that parasites contain elevated pools of 
omithine also offers a hypothesis for the comprutmentalization of ARG to the glycosome. 
Since the pru·asites generate a high atnotmt of omithine, cytosolic ru·ginine would be rapidly 
depleted and not available for protein synthesis if ARG were localized to the cytosol.The 
expetiments desctibed above were perf01med in ru·ginine tich cultme media, which may 
explain why pru·asites proliferated well despite a mislocalized ru·g!!..skl enzyme. 
The Leishmania genome also contains a putative AGM gene (L. mexicana CBZ27141.1); 
however, extensive genetic and biochemical expetiments have demonstrated that this gene 
does not encode a ftmctional AGM or ARG, and targeted gene deletion studies revealed that 
the gene product is not an essential protein (Riley, Robetts, and Ullman, personal 
obsetvations). hlterestingly, an 01t holog of this putative AGM sequence is also present in the 
genomes of the other two tiypanosomatids, T. brucei and T. cntzi. The ADC/AGM altemative 
pathway for pun·escine production clearly does not exist in Leishmania as LJodc null mutants 
ru·e not viable without pun·escine supplementation [32]. 
The Role of Host and Parasite 
Arginase for Infectivity 
Mammalian host cells contain two types of ARG: type I, which is cytosolic and 
expressed at high levels in the liver, and type II, which is located in the mitochondria [94]. hl 
macrophages arginine is a key amino acid for two competing pathways: arginine can be 
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conve1ted to omithine by the action of ARG or altematively to the potent anti-leishmania! 
agent nitric oxide by the inducible nitric oxide synthase (iNOS) [95, 96]. Murine infectivity 
models have documented an increased expression of ARG I in susceptible Balb/c mice 
associated with a TH-2 cell response and increased parasite proliferation [95, 97-101]. 
Conversely, the expression of iNOS has been conelated with a TH-1 cell response and 
decreased parasite loads in the Leishmania resistant CBA mouse model [97, 102, 103]. 
Numerous experiments have now conelate.d increased ARG I activity with augmented 
parasite loads [96, 97, 100]. In addition, phannaceutical inhibition of host ARG has been 
fmmd to reduce parasite numbers in macrophages and 1nice [97, 98, 100]. Thus, the 
mammalian ARG has been fl1mly established as a key factor for Leishmania infections [97-
101, 104-108]. It is not completely understood how increased levels of host ARG I cause or 
contribute to disease exacerbation. One effect of higher ARG activity may be a depletion of 
arginine levels, which could reduce the production of nitric oxide. A local reduction of 
arginine has also been shown to impair the development ofT cells leading to suppression of 
the immune response and increased parasitemia [ 109-111]. Fmthe1more, it has been 
speculated that increased ARG activity enhances the levels of host polyamines, which may be 
salvaged by intracellular parasites and thus increase their proliferation [96, 100, 101]. 
To dete1mine the role of parasite ARG for infectivity, in vitro and in vivo infectivity 
studies have been perfmmed with all three b.arg strains (L. me;-cicana, L. major, and L. 
amazonen.sis b.arg) [37, 90, 91 , 112]. In vitro infectivity studies established that both L. 
mexicana wild type and b.arg parasites were able to scavenge omithine and putrescine from 
the phagolysosome of macrophages incubated in supplemented media. However, 
investigations in BALB/c mice demonstrated that infectivity with L. mexicana b.arg was 
markedly reduced compared to wild type parasites. [37] Similarly, the L. major b.arg and L. 
amazonen.sis b.arg deficient strains exhibited a reduced infectivity phenotype in mice [90, 91, 
112]. The diminished infectivity of the L. me;-cicana b.arg parasites appeared to conelate with 
an increased potential to produce nitric oxide by macrophages infected with L. mexicana b.arg 
parasites compared to macrophages infected with wild type parasites [37]. Fmt he1more, no 
difference in infectivity was obse1ved between L. mexicana wild type and b.arg parasites in 
iNOS-deflcient macrophages. One possible explanation for the obse1vation that L. mexicana 
b.arg parasites are less infective is that the ARG deficient parasites cannot use arginine for 
polyamine production, and consequently have a reduced uptake and need of host arginine. 
This, in tum, would leave the host cell with more arginine available for the synthesis of nitlic 
oxide. Such a conjecture is also plausible because studies have demonstrated that the level of 
the L. donovani LdAAP3 arginine transpo1ter and thus, arginine uptake, is regulated by 
intracellular arginine levels [113]. In addition, it is likely that arginine levels in macrophages 
are limited since they are govemed solely by availability and uptake from the plasma. Indeed, 
macrophages that lack the arginine transpo1ter mCAT2B exhibit reduced levels of both 
polyarnines and nitric oxide [96, 114]. Thus, intracellular amastigotes and the host compete 
for a limited arginine pool and the balance between parasite and host metabolism of arginine 
may be cmcial in dete1mining the outcome of leishmania! infections. 
Intt·iguingly, a conelation between reduced infectivity and increase nitlic oxide 
production was not fmmd in macrophages infected with L. major b.arg, suggesting that 
differences in the various cutaneous Leishmania species and their interactions with the 
mammalian host exist. Overall, a rational explanation for the reduced infectivity of the 
different cutaneous b.arg Leishmania stt·ains is that although omithine or putt·escine can be 
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scavenged from the phagolysosome, endogenous biosynthesis produces more of these 
essential nutrients. 
Taken together, these studies suggest impo11ant roles for both host and parasite arginase 
for optimal parasite infections. Thus, although inhibition of parasite arginase alone would not 
be a sufficient therapeutic strategy, the dual inhibition of host and parasite arginase may 
provide a novel treatment strategy. Inhibition of both enzymes would prevent polyamine 
biosynthesis and may furthe1more stimulate host defense mechanisms like nitric oxide 
production. The amino acid sequence of the Leishmania and human ARG enzyme is ~38% 
identical and the kinetic and biochemical characteristics of the recombinant enzymes are 
similar [115]. A preliminruy screen identified inhibitors that target both recombinant enzymes 
[115], supp01t ing the concept that dual inhibition of human and pru·asite enzyme may be 
possible. 
Polyamine Uptake by leishmania Parasites 
Both promastigotes and amastigotes ru·e able to synthesize polyamines de novo [32, 36] 
and have the ability to transp01t polyamines [85-88]. Studies in L. donovani and L. mexicana 
promastigotes found multiple polyamine transp01t systems, which suggests that different 
transp01ters exist for putrescine and spe1midine uptake [85, 88]. The gene of the first 
eukruyotic polyamine transp01ter was cloned fi:om L. major (LmPOTl) [87]. In order to 
ftmctionally chru·acteiize the putative transp01ter, the gene was expressed in Xenopus laevis 
oocytes and ftuthe1more transfected into the related pru·asite T. brucei, which has poor 
endogenous putrescine transp01t. 
The LmPOTl transp01t er has high affinity for both putrescine and spermidine. However, 
while LmPOTl is expressed in L. major promastigotes, the transp01ter could not be detected 
in amastigotes. A compru·ison between L. me.·dcana promastigotes and amastigotes also 
suggest that dispru·ate transport systems exist in the two different developmental stages of the 
pru·asite [85]. 
Studies moreover revealed that at least putrescine uptake is regulated. Inhibition of ODC 
by DFMO resulted in increased putrescine uptake in promastigotes and conversely, elevated 
concentration of putrescine in the media resulted in decreased putrescine uptake [86, 88] . It is 
well established that intracellulru·levels of polyamines ru·e intiicately regulated in mammalian 
cells and it apperu·s that the same may be tiue for Leishmania parasites. The obse1vation that 
polyamine enzyme ove1producer strains only modestly increase intracellular polyamine levels 
despite profoundly elevated enzyme levels also argues that polyamine pools ru·e conu·olled in 
the parasite [ 46]. 
While polyamine uptake is not c1itical for Leishmania, the imp01t of the amino acid 
ru·ginine is essential. Arginine is vital for both polyamine and protein synthesis. An arginine 
u·anspOit er, AAP3 , has been identified and characte1ized in L. donovani and L. amazonenesis 
[113, 116]. In promastigotes, intracellulru· arginine pools regulate the ammmt of Leishmania 
AAP3 ru·ginine u·anspOiter and thus ru·ginine uptake [113, 116]. It is likely that arginine 
uptake is also regulated in amastigotes and that both pru·asite and host cell compete for 
intracellulru· ru·ginine [37]. 
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Interaction of Host and Parasite Polyamine 
Pathways in Leishmania infections 
Infectivity studies with gene deletion mutants can be used to address whether host 
polyamine metabolism influences parasite polyamine homoeostasis. Ld!lode parasites exhibit 
dramatically reduced infectivity phenotypes in macrophages and mice [36]. Since amastigotes 
are able to transpo1t putrescine, the logical explanation is that insufficient ammmts of host 
putrescine are available. 
Such a conjecture is not unreasonable because host polyamine metabolism is intricately 
regulated and putrescine levels are maintained at constant levels. Thus, it appears that L. 
donovani parasites do not benefit from host putrescine pools but depend on endogenous 
putrescine biosynthesis.The Ld!lspd parasites also show a severely reduced infectivity 
phenotype but to a lesser degree than Ld!lode [38]. 
It should be noted, that spe1midine is the essential and sufficient polyamine in 
promastigotes [32]. Thus, the obse1vation that intracellular Ld!lode amastigotes are more 
incapacitated than Ld!lspd amastigotes is somewhat smprising. Possible explanations include 
that less putrescine than spe1midine is present in the phagolysosome or that L. donovani 
amastigotes have unequal uptake capabilities for the two polyamines. In contrast, Leishmania 
deficient in ARG exhibit only a moderate loss in infectivity compared to the severely reduced 
infectivity of Ld!lode and Ld!lspd parasites. All three ARG deficient strains that were 
generated, L. mexieana, L. major, and L.amazonensis !larg, were still able to establish 
infections [37, 90, 91, 112]. 
The differences in infectivity phenotypes can be rationalized by the assumption that 
omithine is present in higher quantities than putrescine or spe1midine in the phagolysosome 
or that omithine uptake in amastigotes is much more robust than uptake of the polyamines. 
One should recall thought that !larg promastigotes require much higher concentration of 
exogenous omithine than putrescine to allow optimal growth [89, 91], an obse1vation that 
contradicts the hypothesis that amastigotes would be more successful in scavenging omithine 
than putrescine. 
Fmthe1more, it needs to be emphasized that the !lode and !lspd parasites have been 
generated in L. donovani, a visceralizing strain, whereas the !larg deletions were introduced 
into Leishmania species that cause a cutaneous disease. It is feasible that the omithine and 
polyamine milieu of macrophages of the skin is different from that of macrophages residing 
in liver and spleen. 
The generation and direct comparison of !larg, !lode, !lspd mutants within the same 
species is necessary to solve this conundmm. Nevertheless, a model of host and pru·asite 
polyamine metabolism and salvage has been constlucted that can be used as a basis for 
fmther investigations (Figure 5). 
This model speculates that high amounts of omithine are available for pru·asite uptake but 
only limited ammmts of pun·escine and spe1midine ru·e present in the phagolysosome. 
Although the augmented host ARG activity in Leishmania infections has always been 
speculated to produce increased amounts of polyamines for pru·asite salvage, omithine may 
actually be more impo1tant than polyamines for parasite scavenging and enhanced 
proliferation. 
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The polyamine pathway has been investigated in several other protozoan parasites, 
including the tlypanosomatids T. bmcei and T. cniZi. Similar genetic manipulations have 
been petfonned to elucidate the metabolic pathway in T. brucei. In addition to classical 
knockout studies, the technique of RNA interference (RNAi) has been utilized [ 117-120]. 
RNAi has the advantage of allowing inducible knockdown of target gene expression and thus 
facilitates the study of essential genes. However, a drawback of RNAi is that sometimes the 
knockdown is achieved at only prutiallevels and residual enzyme activity may be present. It 
is of interest to note that most Leishmania species have lost the protein repettoire necessruy 
for the RNA silencing machinety. 
Investigations in T. brucei and T. cruzi have discovered a unique regulat01y protein -
prozyme - that is required for ADOMETDC activation [118, 121-123]. This regulat01y 
mechanism is distinct from that of mammalian cells. Prozyme has not been studied in 
Leishmania, but the gene encoding this protein is present in the genome database of several 
Leishmania species and it is thus likely that the Leishmania ADOMETDC also requires 
heterodimetization with prozyme for full activation. 
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Figw-e 5. A model of host and parasite polyatnine metabolism atld pat·asite scavenging. 
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T brucei parasites contain a polyamine biosynthetic pathway similar to Leishmania 
consisting of ARG, ODC, SPD and ADOMETDC [1 17-120, 124-126]. However, in contrast 
to Leishmania, T. brucei parasites are extracellular pathogens that are present in the host's 
blood stream. Polyamine levels in blood are low and thus T brucei is dependent on 
endogenous polyamine biosynthesis [118]. The lack of salvageable polyamines offers an 
explanation for the efficacy of the ODC inhibitor DFMO in the treatment of Aftican sleeping 
sickness. 
The polyamine pathway in T cntzi is more austere than that of the other 
trypanosomatids; they are not able to synthesize putrescine fi.·om amino acid precmsors [127-
130]. Only two other eukruyotes ru·e known to be incapable of de novo polyamine 
biosynthesis: Toxoplasma gondii and Cryptosporidium parvum [ 131, 132]. 
T cntzi parasites lack both ARG and ODC and although an ADC activity was initially 
repo1ted [133, 134], it is now generally accepted that the altemative ADC/AGM pathway 
does not exist in T cntzi. It has been speculated that the trypanosomatids have lost their ODC 
gene followed by ho1izontal gene tr·ansfer of the ODC sequence fi.·om a ve1t ebrate host into T 
brucei [135]. Suppo1t for this hypothesis comes fi.·om phylogenetic analyses, which show the 
T brucei ODC clustered closer to the ODC genes fi.·om ve1t ebrates than protozoans. Because 
of the lack of de novo putr·escine synthesis, T cntzi pru·asites ru·e absolutely dependent on 
putrescine scavenge fi.·om the host. Like Leishmania, T cntzi is an intracellulru· pru·asite taken 
up by phagocytosis. However, T cruzi pru·asites escape the phagosome to reside in the host 
cell cytosol. Thus, the pathogen has access to presumably more abtmdant polyamine pools 
compared to Leishmania pru·asites, which live in phagolysosomes. 
In summruy , the interactions between host and pru·asite that are necessruy to maintain 
polyrunine homeostasis in the pathogen are strikingly different among the three trypanoso-
matid parasites (Figme 6). 
Leishmania parasites reside inside the phagolysosome and although they apperu· to rely 
on endogenous polyamine biosynthesis (L. donovani) they ru·e capable of at least limited 
omithine salvage (L. me;-cicana, L. major, L. amazonensis). T cruzi pru·asites inhabit the 
cytosol and absolutely depend on putr·escine salvage because they ru·e not able to synthesize 
polyrunines de novo. Finally, T brucei parasites ru·e extr·acellulru· pathogens that live in the 
bloodstr·eam - a polyamine poor milieu -and rely on endogenous polyamine biosynthesis. 
Conclusion 
Genetic techniques, foremost the ability to generate gene deletion mutants, have 
facilitated the elucidation of the polyamine biosynthetic pathway in Leishmania pru·asites. 
Fmthe1more, the gene deletion mutants ru·e invaluable tools to investigate the relevance of 
polyrunine biosynthesis for parasite infectivity and the interplay between host and pru·asite 
polyrunine pathways. 
In addition, the ability to generate overproducer strains can be utilized for the develop-
ment of cell-based screening assays that test the mode of action of inhibito1y compounds. In 
this manner, the process of genetic manipulation has been applied to validate the polyamine 
pathway in Leishmania pru·asites as a potential therapeutic target. 
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AT. cruzi amastigotes evade the phagosome to reside free in the cytosol and thus have access to the host 
polyamines putrescine ( + ) and spermidine (• ). Because they are incapable of de novo putrescine 
synthesis they depend on polyamine salvage. BLeishmania anutstigotes proliferate in 
phagolysosomal compartments. They are able to synthesize polyamines and although they can 
salvage ornithine (* ), polyamine uptake appears to be limited. cT. brucei parasites are 
extracellular pathogens and rely on endogenous polyamine synthesis because polyamine levels in 
blood are minute. 
Figme 6. Comparison of host-parasite interactions among trypanosomatid parasites. 
Substantial differences between the polyamine pathways of host and parasite have been 
revealed. Leishmania pathogens lack a back-conversion pathway, do not express spermine 
synthase, and the polyamine biosynthetic enzymes are more stable than their human 
counte1pruts. 
An altemative pathway of putrescine production via ADC and AGM is not present in 
Leishmania, and the putative AGM that is present in the Leishmania gen01nic databases does 
not function as such. Hence, the Leishmania polyaniine pathway consists of only four 
enzymes: ARG, ODC, SPD and ADOMETDC. The hypusination pathway that utilizes 
spemridine for the modification and activation of eiFSA is present in Leishmania and both 
enzymes, DHS and DOHH, have recently been described. Sequence comparisons between the 
host and pru·asite enzymes reveal that similru·ities ru·e moderate, and especially low for DHS 
and ADOMETDC, which may offer tru·gets for selective inhibitor development. Infectivity 
studies with L. donovani gene deletion mutants revealed that the Ld!:J.odc parasites show 
profmmdly reduced infectivity phenotypes compru·ed to wild type pru·asites and validated 
ODC as a therapeutic target. Similru·ly, Ld!:J.spd pru·asites exhibited severely decreased 
infectivity, although not as severely impaired as obse1ved in the LdtJ.odc cell line. These 
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obse1vations challenged the conventional belief that polyamines are abundant in the 
phagolysosomal compartment. 
Conversely, !:,arg strains that were generated in L. mexicana, L. major and L. 
amazonenesis show only moderate reduction in infectivity. These obse1vations suggest that 
omithine levels are much higher than putrescine ar1d spe1midine pools in the phagolysosome. 
Studies suggesting that an increased host ARG activity is cmcial for the exacerbation of 
leishmaniasis and that host polyamine synthesis is tightly regulated suppo1t tltis conjecn1re. 
However, it should be noted that L. donovani is a visceralizing strain whereas L. mexicana, L. 
major ar1d L. amazonenesiscause cutaneous leishmaniasis. Thus, the discrepancies in 
infectivity phenotypes may also be due to differences in the Leishmania species and/or host 
cell type (macrophages of skin versus liver and spleen). 
In conclusion, studies with genetically manipulated Leishmania strains revealed that the 
enzymes of the polyamine biosynthetic pathway, especially ODC and SPD, are potential 
therapeutic targets. FU1the1more, the dual inhibition of host and par·asite polyantine synthesis, 
part icular·ly targeting the host ARG, may have a synergistic effect and is w01thwhile to 
explore. 
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